Lisa Carey, MD, ScM, FASCO, was honored for her distinguished service over the years leading outstanding clinical and translational research and her work in eradicating health disparities.
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
A team of UNC researchers investigated how cell cycle flexibility allows tumor cells to escape the effect of anti-cancer drugs that target cell division.
Missy Van Lokeren was diagnosed with metastatic breast cancer in 2018, and has became a patient advocate spreading awareness for tissue donation through the Patients And Researchers Together (PART) program.
New findings from Gaorav Gupta, MD, PhD, and colleagues show how the cGAS-STING pathway is unleashed to prevent cancer formation by detecting DNA damage within cells.
Yara Abdou, MD, Dominique Higgins, MD, PhD, and Joannie Ivory, MD, recently received career development awards from the Robert A. Winn Diversity in Clinical Trials Program.
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
Sarah Chaires, FNP, never thought that she would slip off the white medical provider lab coat and slip into a patient hospital gown. But everything redirected for the Chaires family when she was diagnosed with HER2-positive breast cancer.
A group of UNC Lineberger researchers led by Katie Reeder-Hayes, MD, MSc, MBA, will develop new methods to measure and map cancer screening across North Carolina.
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
Recent research shows cancer among younger Americans, especially women, is on the rise. UNC Lineberger’s Melissa Troester, PhD, a cancer epidemiologist, breaks down the data and shares what it means for the future of women’s health.
Kristalyn Gallagher, DO, and colleagues have developed an AI model that can predict whether or not cancerous tissue has been fully removed from the body during breast cancer surgery.
UNC Lineberger members and trainees will present cancer research findings at the 2023 American Society of Clinical Oncology annual meeting in Chicago, June 2-6.
H. Shelton “Shelley” Earp, MD, director of the UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care, received the prestigious Oliver Max Gardner Award.